Navigation Links
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
Date:10/17/2007

Latest Randomized Clinical Trial Results of First Pro-Healing Stent Also

Featured at Annual Symposium

HONG KONG, Oct. 18 /PRNewswire/ -- OrbusNeich's Genous(TM) Bio-engineered R stent(TM) is the subject of several sessions about innovation in interventional cardiology strategies and device design at this year's Transcatheter Cardiovascular Therapeutics symposium, TCT 2007, which is set for Oct. 20-25 at the Washington Convention Center in Washington, D.C.

The line-up of sessions that feature the first pro-healing stent, which is an alternative to drug-eluting stents, includes:

- Interventional Strategies and Adjunct Pharmacology in ACS and AMI;

Should Specialized DES for AMI be Developed? Early Experience with EPC

Capture Technology; Jan Henk Dambrink, M.D., Ph.D., Department of

Cardiology, ISALA Klinieken, Hospital De Weezenlanden, Zwolle, The

Netherlands; 2:10 p.m. EDT on Oct. 21; Room 151B

- Innovative Devices and Futuristic Concepts: Novel Bare Metal and Drug-

Eluting Stents; The Genous Stent Coating with CD34 Antibodies to

Actively Capture Circulating EPCs: Design Parameters and Effects on

Healing and Thrombogenicity; Michael Kutryk, M.D., clinician scientist

and interventional cardiologist at St. Michael's Hospital, assistant

professor at the University of Toronto; Canada; 3:08 p.m. EDT on Oct.

21; Room 152A

In addition, the latest results from clinical trials of the Genous stent will be discussed by Robbert de Winter, M.D., Ph.D., principal investigator and director of the catheterization laboratory at the Academic Medical Center in Amsterdam. Specifically, de Winter will present:

- Updates from the HEALING studies, AMC "Real World" registry and TRIAS

trial; 4:36 p.m. EDT on Oct. 21; Ballroom C, 3rd floor

- A late-breaking report of six-month clinical outcomes from the TRIAS HR

pilot study: a
'/>"/>

SOURCE OrbusNeich
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Efficacy of OrbusNeichs Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
2. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
3. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
4. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
5. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
6. Pharmathenes Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimers Research
7. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimers Research
8. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
9. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
10. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Calif., Dec. 14 Accuray Incorporated (Nasdaq: ... field of radiosurgery, announced today that the first ... installed at the University Hospital of Liege. ... hospital, is one of the largest hospitals in ... ,, "With a full range of cancer ...
(Date:12/14/2009)... Dec. 14 The U.S. ... (olanzapine) For Extended Release Injectable Suspension for the ... Company (NYSE: LLY ) announced today. ... delivery of olanzapine for up to four weeks. ... formulations, long-acting formulations of antipsychotics allow for stable ...
(Date:12/14/2009)... 14 CPG International, Inc., manufacturer ... products, introduces VYCOM, a rebranded business unit. ... VYCOM Corporation and Scranton Products Industrial business ... business unit within CPG International, Inc. alongside ... The VYCOM business unit has new, redefined ...
Breaking Medicine Technology:First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Improving schools for disabled students is NJIT researchers mission 59864 1Improving schools for disabled students is NJIT researchers mission 59864 2Improving schools for disabled students is NJIT researchers mission 59864 3UF scientists discover new explanation for controversial old patient care technique 10446 1UF scientists discover new explanation for controversial old patient care technique 10446 2UF scientists discover new explanation for controversial old patient care technique 10446 3Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 1Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 2Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 3Keystone Mercy Health Plan Initiative Brings Cancer Screenings to Underserved Women in Their Communities 59860 4
... enrollment into the GRAVITAS,(Gauging Responsiveness With A VerifyNow(R) ... from Accumetrics announced today. The,GRAVITAS trial is designed ... test,to identify patients that exhibit a low response ... cardiac events, and prove that these at-risk,patients will ...
... the efficacy of RESPeRATE while highlighting ... BERLIN and NEW YORK, June 16 European Society ... Ltd., a medical device,company publicly traded on the Tel-Aviv ... studies and analysis highlighting RESPeRATE,-- the only medical device ...
Other Medicine Technology:Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial 2Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial 3Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 2Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 3Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 4
(Date:12/14/2009)... years under government controlled health care, before moving to the U.S. ... and in his new book, Health Reform: The End of the ... system and its threat to real health care! , ... ... diagnostic radiologist from Minnesota, warns Americans not to sell out their ...
(Date:12/14/2009)... Ohio, Dec. 14 Skilled nursing facilities (SNFs) ... services in order to deal with a 92 percent ... fee) from $6.25 to $12.01 per bed per day, ... the average facility will pay an additional $17,520 to ... a total tax of $438,365 yearly. ,, Nearly 96 ...
(Date:12/14/2009)... Grubb & Ellis Healthcare REIT II, Inc. announced today that ... stockholders of record as of the close of business on ... and ending on Feb. 28, 2010. The distributions will ... and will be equal to an annualized distribution rate of ... These distributions will be aggregated and paid in cash ...
(Date:12/14/2009)... BOSTON, Dec. 14 When Kurth Krause, ... crew instructions for landing on the moon, he,was ... about anything.,Years later, Kurth realized there was one ... a kidney transplant and even though dialysis machines,would ... without a transplant. Kurth,wrote: "My wife is 69 ...
(Date:12/14/2009)... and shouldn,t worry most users, researcher says , , MONDAY, ... antidepressants may have a small but statistically significant increased ... on the medications, a new study finds. , "But ... Dr. Jordan W. Smoller, an associate professor of psychiatry ... report in the Dec. 14 issue of Archives ...
Breaking Medicine News(10 mins):Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 2Health News:Grubb & Ellis Healthcare REIT II Declares Initial Distribution 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3
... Wins Competitive Bid to Support NIH Information Sharing ... one of the Washington region,s leading providers of ... blanket purchase agreement (BPA) by the National Institutes ... services. The BPA, effective February 18, 2009, covers ...
... device company, Intelligent Hospital Systems (IH Systems), has entered ... SA ( www.palexmedical.es ) for the provision of sales ... IV Automation). Palex has more than 50 years of ... efficient solutions to hospitals. , Taking advantage of global ...
... world that tells parents of autistic children to "accept" ... not only hope, but actual help, to these families. ... with autism. Seeing his patients improve with hyperbaric oxygen ... double-blind, controlled study to examine its effectiveness. And, ...
... Objects Adds ICD-10-WHO and ICD-10-CA Extensions to ... 25 Intelligent Medical Objects (IMO(R)) announces ... extensions to their market-leading line of Clinical ... IMO Problem (IT) is a clinical ...
... spiders, a tiny chirping frog and an elegant striped ... discovered during a Conservation International (CI) Rapid Assessment Program ... The discoveries were announced today following analysis of the ... 2008 during a month-long exploration of Papua New Guinea,s ...
... world,s leading medical,technology journal - is calling for a public ... light of discrepancies over the risk of,exposure to asbestos at ... the day of a parliamentary debate on the presence of ... extent,of the problem and the ensuing healthcare need, add weight ...
Other Medicine News:Health News:NIH Awards Blanket Purchase Agreement (BPA) to Citizant 2Health News:Autism Study Finds Significant Benefit with Hyperbaric Treatment 2Health News:Autism Study Finds Significant Benefit with Hyperbaric Treatment 3Health News:Intelligent Medical Objects Announces ICD-10 Extensions to Terminology Products 2Health News:Intelligent Medical Objects Announces ICD-10 Extensions to Terminology Products 3Health News:Intelligent Medical Objects Announces ICD-10 Extensions to Terminology Products 4Health News:Spiders, frogs and gecko among exciting discoveries found in Papua New Guinea 2Health News:Spiders, frogs and gecko among exciting discoveries found in Papua New Guinea 3Health News:Westminster Safety Disagreement Highlights Risk in Schools 2Health News:Westminster Safety Disagreement Highlights Risk in Schools 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: